Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

NCT06656598 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Stage III NSCLC

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Cemiplimab
RADIATION: Curative hypofractionated radiotherapy
DRUG: Cemiplimab (maintenance)

Sponsor

Intergroupe Francophone de Cancerologie Thoracique